e-learning
resources
Virtual 2021
05.09.2021
Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Management of refractory dyspnoea in COPD
D. Janssen (Horn, Netherlands)
Source:
Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Session:
Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Session type:
Journal session
Number:
1353
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Janssen (Horn, Netherlands). Management of refractory dyspnoea in COPD. Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Management of chronic breathlessness
Source: Eur Respir Monogr 2016; 73: 153-171
Year: 2016
Chronic refractory cough
Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines
Year: 2020
Determinants of dyspnea in stable COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011
Management of acute COPD exacerbations
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013
Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness
Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016
Year: 2017
Management of refractory dyspnoea in end-stage patients: the use of noninvasive respiratory support
Source: Virtual Congress 2021 – Noninvasive respiratory support in hypoxic respiratory failure: stay safe and know your limits
Year: 2021
Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019
Non-pharmacological management of dyspnoea and cough in COPD
Source: International Congress 2014 – Primary Care Programme "Management of COPD and other respiratory conditions in clinical practice"
Year: 2014
Mechanisms of exertional dyspnoea in symptomatic smokers without COPD
Source: Eur Respir J 2016; 48: 694-705
Year: 2016
Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015
Acute management of COPD exacerbations
Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview
Year: 2012
Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Chronic cough in COPD
Source: Annual Congress 2003 - New pathophysiological aspects in COPD
Year: 2003
Outcome of pulmonary rehabilitation in patients after acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013
Overdiagnosis of COPD and asthma among elderly with chronic dyspnea
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021
Impact of anemia on dyspnea on exertion and exercise tolerance in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2011 - Exercise assessment in different diseases
Year: 2011
Mechanisms of orthopnea in patients with advanced COPD
Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Year: 2019
Assessing COPD profiles and outcomes by dyspnoea severity
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Strategy for the intractable pneumothoracs treatment in the patients with COPD
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept